$3.17
0.062.09%
At Close: -
$3.14
-0.03-0.95%
After Hours: 4:38 PM EDT
15 minutes delayed
Petco Health and Wellness (NASDAQ:WOOF) 주식, 분석가 평가, 목표 가격, 예측
Petco Health and Wellness Co Inc의 합의된 목표 주가는 75개의 최신 애널리스트 평가를 살펴보고 설정되었습니다. 마지막 3개의 애널리스트 평가는 5월 29, 2024, 5월 24, 2024 및 5월 23, 2024에 Wedbush, RBC Capital 및 Needham에서 발표되었습니다. Wedbush, RBC Capital 및 Needham 사이의 평균 목표 주가는 $4로, 이러한 3개의 애널리스트 평가에서 Petco Health and Wellness Co Inc에 대한 암시된 27.39% upside가 있습니다.
추천을 하는 애널리스트 회사들1
Wedbush
RBC Capital
Needham
UBS
Citigroup
1애널리스트 평가로부터 계산됨
Petco Health and Wellness에 대한 애널리스트 평점
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 05/29/2024 | Buy Now | 27.39% | Wedbush | Seth Basham | $4 → $4 | Reiterates | Outperform → Outperform | Get Alert |
| 05/24/2024 | Buy Now | -4.46% | RBC Capital | Steven Shemesh | $2.7 → $3 | Maintains | Outperform | Get Alert |
| 05/23/2024 | Buy Now | 59.24% | Needham | Anna Andreeva | → $5 | Reiterates | Buy → Buy | Get Alert |
| 05/23/2024 | Buy Now | 27.39% | Wedbush | Seth Basham | $3 → $4 | Maintains | Outperform | Get Alert |
| 05/23/2024 | Buy Now | 3.5% | UBS | Michael Lasser | $2.5 → $3.25 | Maintains | Neutral | Get Alert |
| 05/07/2024 | Buy Now | -44.27% | Citigroup | Steven Zaccone | $2.85 → $1.75 | Maintains | Neutral | Get Alert |
| 04/02/2024 | Buy Now | -52.23% | B of A Securities | Elizabeth Suzuki | $5 → $1.5 | Downgrade | Buy → Underperform | Get Alert |
| 03/25/2024 | Buy Now | -36.31% | Wells Fargo | Zachary Fadem | $3 → $2 | Maintains | Equal-Weight | Get Alert |
| 03/20/2024 | Buy Now | -20.38% | UBS | Michael Lasser | $3 → $2.5 | Maintains | Neutral | Get Alert |
| 03/15/2024 | Buy Now | -14.01% | RBC Capital | Steven Shemesh | $3.5 → $2.7 | Maintains | Outperform | Get Alert |
| 03/15/2024 | Buy Now | -4.46% | Evercore ISI Group | Oliver Wintermantel | $4 → $3 | Maintains | In-Line | Get Alert |
| 03/14/2024 | Buy Now | -20.38% | Baird | Justin Kleber | $3 → $2.5 | Maintains | Neutral | Get Alert |
| 03/13/2024 | Buy Now | 59.24% | Needham | Anna Andreeva | $5 → $5 | Maintains | Buy | Get Alert |
| 12/19/2023 | Buy Now | -0.96% | Jefferies | Kaumil Gajrawala | → $3.11 | Initiates | → Hold | Get Alert |
| 12/04/2023 | Buy Now | -4.46% | Morgan Stanley | Simeon Gutman | $5 → $3 | Maintains | Equal-Weight | Get Alert |
| 12/04/2023 | Buy Now | 11.46% | RBC Capital | Steven Shemesh | $7 → $3.5 | Maintains | Outperform | Get Alert |
| 11/30/2023 | Buy Now | 59.24% | Goldman Sachs | Kate McShane | $7 → $5 | Maintains | Buy | Get Alert |
| 11/30/2023 | Buy Now | 11.46% | Wedbush | Seth Basham | $4.5 → $3.5 | Maintains | Outperform | Get Alert |
| 11/29/2023 | Buy Now | 59.24% | Needham | Anna Andreeva | $8 → $5 | Maintains | Buy | Get Alert |
| 11/29/2023 | Buy Now | — | Wells Fargo | Zachary Fadem | — | Downgrade | Overweight → Equal-Weight | Get Alert |
| 10/31/2023 | Buy Now | 43.31% | Wedbush | Seth Basham | $6 → $4.5 | Maintains | Outperform | Get Alert |
| 09/29/2023 | Buy Now | — | Wolfe Research | Greg Badishkanian | — | Initiates | → Peer Perform | Get Alert |
| 09/08/2023 | Buy Now | 154.78% | Evercore ISI Group | Oliver Wintermantel | $6 → $8 | Maintains | In-Line | Get Alert |
| 08/25/2023 | Buy Now | 218.47% | B of A Securities | Elizabeth Suzuki | $12 → $10 | Maintains | Buy | Get Alert |
| 08/25/2023 | Buy Now | 59.24% | Morgan Stanley | Simeon Gutman | $9 → $5 | Maintains | Equal-Weight | Get Alert |
| 08/25/2023 | Buy Now | 122.93% | RBC Capital | Steven Shemesh | $10 → $7 | Maintains | Outperform | Get Alert |
| 08/25/2023 | Buy Now | 91.08% | Wedbush | Seth Basham | $9 → $6 | Maintains | Outperform | Get Alert |
| 08/25/2023 | Buy Now | 122.93% | Wells Fargo | Zachary Fadem | $11 → $7 | Maintains | Overweight | Get Alert |
| 08/25/2023 | Buy Now | 154.78% | Needham | Anna Andreeva | $12 → $8 | Maintains | Buy | Get Alert |
| 08/16/2023 | Buy Now | 186.62% | Wedbush | Seth Basham | $10 → $9 | Maintains | Outperform | Get Alert |
| 05/26/2023 | Buy Now | 282.17% | B of A Securities | Elizabeth Suzuki | $14.5 → $12 | Maintains | Buy | Get Alert |
| 05/26/2023 | Buy Now | 218.47% | RBC Capital | Steven Shemesh | → $10 | Reiterates | Outperform → Outperform | Get Alert |
| 05/25/2023 | Buy Now | 186.62% | Morgan Stanley | Simeon Gutman | $10 → $9 | Maintains | Equal-Weight | Get Alert |
| 05/24/2023 | Buy Now | 282.17% | Needham | Anna Andreeva | $15 → $12 | Maintains | Buy | Get Alert |
| 05/22/2023 | Buy Now | 250.32% | Wedbush | Seth Basham | → $11 | Reiterates | Outperform → Outperform | Get Alert |
| 04/28/2023 | Buy Now | 218.47% | Gordon Haskett | Greg Sommer | → $10 | Initiates | → Hold | Get Alert |
| 04/14/2023 | Buy Now | 377.71% | Needham | Anna Andreeva | $20 → $15 | Maintains | Buy | Get Alert |
| 03/29/2023 | Buy Now | 361.78% | B of A Securities | Elizabeth Suzuki | $18 → $14.5 | Maintains | Buy | Get Alert |
| 03/28/2023 | Buy Now | 170.7% | Citigroup | Steven Zaccone | $11 → $8.5 | Maintains | Neutral | Get Alert |
| 03/23/2023 | Buy Now | 218.47% | Evercore ISI Group | Oliver Wintermantel | $12 → $10 | Maintains | In-Line | Get Alert |
| 03/23/2023 | Buy Now | 218.47% | RBC Capital | Steven Shemesh | $14 → $10 | Maintains | Outperform | Get Alert |
| 03/23/2023 | Buy Now | 218.47% | Morgan Stanley | Simeon Gutman | $12 → $10 | Maintains | Equal-Weight | Get Alert |
| 03/23/2023 | Buy Now | 250.32% | Baird | Justin Kleber | $14 → $11 | Maintains | Outperform | Get Alert |
| 03/23/2023 | Buy Now | 536.94% | Needham | Anna Andreeva | → $20 | Reiterates | → Buy | Get Alert |
| 03/15/2023 | Buy Now | 282.17% | Wells Fargo | Zachary Fadem | $14 → $12 | Maintains | Overweight | Get Alert |
| 03/13/2023 | Buy Now | 250.32% | Citigroup | Steven Zaccone | → $11 | Downgrade | Buy → Neutral | Get Alert |
| 02/09/2023 | Buy Now | 345.86% | RBC Capital | Steven Shemesh | → $14 | Reiterates | → Outperform | Get Alert |
| 01/17/2023 | Buy Now | 282.17% | Morgan Stanley | Simeon Gutman | $14 → $12 | Maintains | Equal-Weight | Get Alert |
| 12/02/2022 | Buy Now | 345.86% | Morgan Stanley | Simeon Gutman | $19 → $14 | Maintains | Equal-Weight | Get Alert |
| 12/01/2022 | Buy Now | 409.55% | Goldman Sachs | Kate McShane | $18 → $16 | Maintains | Buy | Get Alert |
| 12/01/2022 | Buy Now | 409.55% | RBC Capital | Steven Shemesh | $17 → $16 | Maintains | Outperform | Get Alert |
| 12/01/2022 | Buy Now | 282.17% | UBS | Michael Lasser | $16 → $12 | Maintains | Neutral | Get Alert |
| 11/28/2022 | Buy Now | 536.94% | Needham | Anna Andreeva | $30 → $20 | Maintains | Buy | Get Alert |
| 11/18/2022 | Buy Now | 345.86% | Wells Fargo | Zachary Fadem | $19 → $14 | Maintains | Overweight | Get Alert |
| 10/19/2022 | Buy Now | 282.17% | Evercore ISI Group | Oliver Wintermantel | $15 → $12 | Downgrade | Outperform → In-Line | Get Alert |
| 10/04/2022 | Buy Now | 473.25% | Goldman Sachs | Kate McShane | $20 → $18 | Maintains | Buy | Get Alert |
| 09/26/2022 | Buy Now | 505.1% | Wells Fargo | Zachary Fadem | $22 → $19 | Maintains | Overweight | Get Alert |
| 09/07/2022 | Buy Now | 441.4% | RBC Capital | Steven Shemesh | → $17 | Initiates | → Outperform | Get Alert |
| 08/25/2022 | Buy Now | 505.1% | Morgan Stanley | Simeon Gutman | $21 → $19 | Maintains | Equal-Weight | Get Alert |
| 08/12/2022 | Buy Now | 600.64% | Wells Fargo | Zachary Fadem | $27 → $22 | Maintains | Overweight | Get Alert |
| 07/26/2022 | Buy Now | 473.25% | Wedbush | Seth Basham | $25 → $18 | Maintains | Outperform | Get Alert |
| 06/27/2022 | Buy Now | 568.79% | Goldman Sachs | Kate McShane | $23 → $21 | Maintains | Buy | Get Alert |
| 05/25/2022 | Buy Now | 536.94% | Citigroup | Steven Zaccone | $26 → $20 | Maintains | Buy | Get Alert |
| 05/25/2022 | Buy Now | 568.79% | Baird | Peter Benedict | $25 → $21 | Maintains | Outperform | Get Alert |
| 05/16/2022 | Buy Now | 568.79% | Morgan Stanley | Simeon Gutman | → $21 | Initiates | → Equal-Weight | Get Alert |
| 05/13/2022 | Buy Now | 728.03% | Citigroup | Steven Zaccone | $28 → $26 | Maintains | Buy | Get Alert |
| 04/14/2022 | Buy Now | 791.72% | Citigroup | Steven Zaccone | $26 → $28 | Maintains | Buy | Get Alert |
| 03/29/2022 | Buy Now | 696.18% | Wedbush | Seth Basham | $23 → $25 | Maintains | Outperform | Get Alert |
| 12/16/2021 | Buy Now | 855.41% | Needham | Anna Andreeva | — | Initiates | → Buy | Get Alert |
| 12/06/2021 | Buy Now | 632.48% | Wedbush | Seth Basham | — | Upgrade | Neutral → Outperform | Get Alert |
| 11/19/2021 | Buy Now | 823.57% | Citigroup | — | — | Maintains | Buy | Get Alert |
| 11/15/2021 | Buy Now | — | Jefferies | Stephanie Wissink | — | Downgrade | Buy → Hold | Get Alert |
| 08/20/2021 | Buy Now | 791.72% | Credit Suisse | Lavesh Hemnani | — | Upgrade | Neutral → Outperform | Get Alert |
| 08/06/2021 | Buy Now | 664.33% | Jefferies | Stephanie Wissink | — | Initiates | → Buy | Get Alert |
| 07/16/2021 | Buy Now | 409.55% | BNP Paribas | — | — | Initiates | → Underperform | Get Alert |
FAQ
Petco Health and Wellness (WOOF) 주식의 목표가는 얼마인가요?
Petco Health and Wellness (NASDAQ:WOOF)의 최신 목표 주가는 5월 29, 2024에 Wedbush에 의해 보고되었습니다. 이 애널리스트 기관은 $4.00에 대한 가격 목표를 설정했으며, 12개월 이내에 WOOF이(가) rise될 것으로 예상합니다 (가능한 27.39% upside). 지난 1년간 30개의 애널리스트 기관이 평가를 보고했습니다.
Petco Health and Wellness (WOOF)에 대한 가장 최근의 애널리스트 평가는 무엇인가요?
Petco Health and Wellness (NASDAQ:WOOF)에 대한 최신 애널리스트 평가는 Wedbush에 의해 제공되었으며, Petco Health and Wellness은(는) outperform 평가를 재강조했다합니다.
Petco Health and Wellness (WOOF)에 대한 마지막 업그레이드는 언제 있었나요?
Petco Health and Wellness Co Inc에 대한 마지막 업그레이드는 12월 6, 2021에 발생했습니다. 이 때 Wedbush는 $23로 가격 목표를 올렸습니다. Wedbush는 이전에 Petco Health and Wellness Co Inc에 대해 a neutral를 가지고 있었습니다.
Petco Health and Wellness (WOOF)에 대한 마지막 다운그레이드는 언제 있었나요?
Petco Health and Wellness Co Inc에 대한 마지막 다운그레이드는 4월 2, 2024에 발생했습니다. 이 때 B of A Securities가 Petco Health and Wellness Co Inc에 대해 가격 목표를 $5에서 $1.5로 변경했습니다.
Petco Health and Wellness (WOOF)에 대한 다음 애널리스트 평가는 언제 게시 또는 업데이트될 예정인가요?
애널리스트들은 주식 평가를 내리기 위해 철저한 연구를 진행합니다. 이 연구에는 공개된 재무 보고서를 검토하고, Petco Health and Wellness의 경영진 및 고객과 대화하며, 실적 회의 통화를 듣는 것이 포함됩니다. 대부분의 애널리스트들은 이를 매 분기마다 수행하므로, 한 해에는 회사당 애널리스트 당 4번의 평가를 받을 수 있습니다. Petco Health and Wellness에 대한 마지막 평가는 5월 29, 2024에 제출되었으므로, 다음 평가가 5월 29, 2025쯤에 제공될 것으로 예상됩니다.
애널리스트 평가 Petco Health and Wellness (WOOF)가 올바른가요?
평가는 주관적이며 변할 수 있지만, 최신 Petco Health and Wellness (WOOF) 평가는 재강조했다로, 가격 목표는 $4.00에서 $4.00으로 조정되었습니다. 현재 Petco Health and Wellness (WOOF)의 가격은 $3.14로, 이는 애널리스트의 예측 범위에서 out of입니다.
검색 애널리스트 평가 및 가격 목표 모든 주식에 대한
사람들이 또한 지켜본다
© 2024 Benzinga | All Rights Reserved